TGN1412 and The Lancet's solicitation of reports of phase I trials

Lancet. 2006 Dec 23;368(9554):2206-7. doi: 10.1016/S0140-6736(06)69885-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials, Phase I as Topic*
  • Humans
  • Periodicals as Topic
  • Publication Bias*
  • Registries

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • TGN-1412